Janssen Research & Development, LLC

Works in Cardiovascular · Dermatology · Genetic & rare · GI & liver · Hematology · Immunology · Infectious disease · Metabolic & endocrine · Musculoskeletal · Neurology · Oncology · Ophthalmology · Psychiatry · Renal & urogenital · Respiratory · Women's health

Janssen Research & Development, LLC is a clinical trial sponsor. It has 167 active clinical trials with 95,459 planned participants, across 16 therapeutic areas. Since 2021 it has completed 361 trials and stopped 71 early.

Trial track record · since 2021

167Active trials95,459 planned participants
361Completed175 with results posted
71Stopped early16% of finished trials

Pipeline · 167 active trials

StageTrialStatus

Questions about Janssen Research & Development, LLC

See the rest of this profile

A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.

Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-11-05.

Approve Suite is not affiliated with Janssen Research & Development, LLC.

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.